Actively Recruiting
Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
Led by University of Sydney · Updated on 2024-07-30
50
Participants Needed
5
Research Sites
210 weeks
Total Duration
On this page
Sponsors
U
University of Sydney
Lead Sponsor
C
Calvary Mater Newcastle, Australia
Collaborating Sponsor
AI-Summary
What this Trial Is About
This observational study will investigate the properties of image files standardly collected during radiation therapy treatment in a cross-section of liver cancer patients who received stereotactic ablative body radiation therapy (SABR) after trans-catheter arterial chemo emobilisation (TACE). Specifically, it will determine whether the radio-opaque contrast agents in the image files can be detected by tumour-tracking software (KIM).
CONDITIONS
Official Title
Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Received or will receive stereotactic ablative body radiotherapy (SABR) treatment for liver cancer at a participating site.
- Received a radio-opaque contrast agent (e.g. Lipiodol123 or DC Bead LUMI123) visible on the radiation treatment planning CT scan.
- The radio-opaque contrast agent mass is or will be within the x-ray imaging field of view during the CBCT scan and any planned intra-fraction imaging.
- Provides written informed consent or meets criteria for waiving consent if retrospectively recruited.
You will not qualify if you...
- Younger than 18 years of age.
- Minimum image dataset is not available.
- Image dataset is not in a compatible format.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Calvary Mater Newcastle Hospital
Waratah, New South Wales, Australia, 2298
Not Yet Recruiting
2
Westmead Hospital
Westmead, New South Wales, Australia, 2145
Not Yet Recruiting
3
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia, 4102
Actively Recruiting
4
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia, 3000
Not Yet Recruiting
5
The Austin Hospital
Melbourne, Victoria, Australia, 3000
Not Yet Recruiting
Research Team
S
Shona Silvester
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here